Non-Addictive Battlefield Pain Management Solutions

The contract seeks the development of non-opioid analgesics or alternative pain relief technologies designed for military use in austere environments, with a focus on creating effective, non-addictive solutions that can be deployed in combat or field conditions where traditional pain management options are impractical or risky. The work must address the unique challenges of battlefield medicine, including limited resources, extreme climates, and the need for rapid, reliable pain control without the potential for dependency or misuse. The technology must be robust, easily transportable, and compatible with existing military medical protocols and equipment. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, and is governed by the NAICS code 325412 for pharmaceutical preparation manufacturing. Proposals must be submitted by October 30, 2026, and performance will center in Frederick, with no specific city, state, or zip provided beyond that location. There is no set-aside classification applied to this opportunity, and while no point of contact is listed, interested parties can access additional details through the provided SAM.gov link. The initiative reflects a strategic priority to reduce reliance on opioid-based treatments in military healthcare and advance innovations that enhance soldier readiness and long-term health outcomes.